Clinical Trial Update: Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia [Phase 2, Phase 3]

View source ↗

Summary

A cross-over study evaluated armodafinil for daytime sleepiness associated with treated nocturia; the trial completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Excessive Daytime Sleepiness
• Nocturia

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

Sponsor: Duke University | Conditions: Nocturia, Daytime Sleepiness | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-03-24